The Biological Role of Cervical Cancer Suppressor 3 (CCS-3): Literature Review
- Authors
-
-
Luigi Cristiano
R&D Division, Prestige, Loro Ciuffenna (AR), Italy
-
- Keywords:
- Cancer, EEFs, Cervical cancer suppressor 3 (CCS-3), EEF1A, Apoptosis.
- Abstract
-
CCS-3 is one of the isoforms of eEF1A1, the key protein of the translation elongation step. Discovered in 2006, it has been the subject of some studies on human cervical cancer cell lines and cervical cancer samples. These studies brought to identify its probable role as a transcriptional co-repressor but other functions are currently unknown. It has also been shown that it is able to inhibit cell growth and induce apoptosis in the tumor cells that downregulate it. Further studies could highlight its functions and its possible usefulness as a tumor marker. This review aims to brief the research about CCS-3 that has been carried out so far.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 30-12-2021
- Issue
- Vol. 10 (2021)
- Section
- Articles
How to Cite
Similar Articles
- Anna Gu, Albert I. Wertheimer, The Many Aspects of Off-Label Prescribing in Oncology , Journal of Cancer Research Updates: Vol. 2 No. 2 (2013)
- Michael J. Gonzalez, Jorge R. Miranda-Massari, Jorge Duconge, Miguel J. Berdiel, Jose Olalde, Ascorbic Acid in Combination with Chemotherapeutic Agents for Cancer , Journal of Cancer Research Updates: Vol. 11 (2022)
- Lin Gao, Qinhe Yang, Wenbin Zhou, Yong Dai, Jigang Wang, Li Fu, Pan Zhao, Jingy Huang, Malin Hong, Jinquan Xia, Chang Zou, RNA-Sequencing-Based lncRNA Biomarker Profiling on Triple Negative Breast Cancer , Journal of Cancer Research Updates: Vol. 10 (2021)
- Nan Yao, Dao-Lu Liu, Ying-Jie Li, Zhe-Sheng Chen, Zhi Shi, Wei-Min Chen, Zhe Yao, Dong-Mei Zhang, Wen-Cai Ye, B5H7, a Morpholine Derivative of 23-Hydroxybetulinic Acid, Reverses Doxorubicin Resistance in HepG2/ADM , Journal of Cancer Research Updates: Vol. 3 No. 1 (2014)
- Carolina Bellera, Melisa E. Gantner, María E. Ruiz, Alan Talevi, Recent Advances on Nanotechnology Applications to Cancer Drug Therapy , Journal of Cancer Research Updates: Vol. 2 No. 3 (2013)
- Altin Goxharaj, Nizom Suyunov, Evgeni Nikolaev, Aliia Bazhanova, Natalia Li, Current Developments and Innovations in Early Detection and Subsequent Treatment of Cancer , Journal of Cancer Research Updates: Vol. 13 (2024)
- M.C. Shanker, V. Gokula Krishnan, D. Arul Kumar, M. Bhuvaneswari, K. Sathyamoorthy, B. Prathusha Laxmi, Tri-Modal Bone Cancer Intelligence: Late-Fusion and Cross-Modal Attention over Radiographs, WSIs, and Omics , Journal of Cancer Research Updates: Vol. 15 No. 1 (2026)
- Yang-Hui Huang, Sung-Han Hsiao, Chung-Pu Wu, Isoreserpine Reverses Multidrug Resistance Mediated by ABCB1 , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
- Kamlesh Sodani, Amit K. Tiwari, Chun-Ling Dai, Alaa H. Abuznait, Atish Patel, Zhi-Jie Xiao, Charles R. Ashby, Amal Kaddoumi, Li-Wu Fu, Zhe-Sheng Chen, Sildenafil Enhances the Anticancer Activity of Paclitaxel in an ABCB1-Mediated Multidrug Resistance Xenograft Mouse Model , Journal of Cancer Research Updates: Vol. 3 No. 3 (2014)
- Hossein Mozdarani, Zainab Kouchak Mashkdouz, The Potent Regulatory Role of Circular RNAs in Breast Cancer Development, Diagnosis and Treatment: An Update , Journal of Cancer Research Updates: Vol. 11 (2022)
You may also start an advanced similarity search for this article.